Development and evaluation of influenza pandemic vaccines

Lancet Infect Dis. 2006 Feb;6(2):71-2. doi: 10.1016/S1473-3099(06)70364-4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adjuvants, Immunologic
  • Disease Outbreaks / prevention & control*
  • Drug Approval
  • Global Health
  • Humans
  • Influenza A Virus, H5N1 Subtype / genetics
  • Influenza A Virus, H5N1 Subtype / immunology*
  • Influenza Vaccines* / adverse effects
  • Influenza, Human / immunology
  • Influenza, Human / prevention & control*
  • Safety
  • Vaccines, Attenuated
  • Vaccines, DNA

Substances

  • Adjuvants, Immunologic
  • Influenza Vaccines
  • Vaccines, Attenuated
  • Vaccines, DNA